 |
| Drug classes A, B and C to remain |
UK drug enforcement officials say a new drug has taken hold in Britain, pushing 'traditional' class A drugs aside.
Code-named "1D10C", the new drug comes in powdered and liquid form, and can be administered through any external body orifice, with many even preferring to receive it in the form of inhalers, eye drops and ear drops, making detection almost impossible.
Effects include unexplained euphoria, self-confidence and loquaciousness - the tendency to be overly talkative.
Side effects include paranoia, delusional episodes, lack of concentration, the inability to grasp complex problems, lack of empathy and poor verbal and non-verbal reasoning.
While not yet classified, officials have begun investigating the sources and usage patterns of 1D10C in Britain. Recent admissions of drug usage among political candidates has drawn officers' attention to their ranks, as well as individuals working in media, public relations and political lobbying organisations, as well as large political donors.
While declining to give further details or to be named, one senior investigator said, "We see the flow of political donations in support of projects that are obviously flawed or based on a mistaken understanding of how certain processes or industries work as likely indicators that this drug may be being distributed and abused in large quantities." She declined to say when the investigation would end, or the likely outcome, but one possible result would be a recommendation that the drug be classified in order to restrict its availability.
Both the Conservative Party and the Labour Party declined the opportunity to comment.
